Hosted on MSN
Pacira ends hip osteoarthritis injection study for ZILRETTA: What investors should know
Pacira (PCRX) announced an update on their ongoing clinical study. Study Overview: Pacira Pharmaceuticals is running a Phase 2 trial titled “A Phase 2, Randomized, Open-Label, Two-Arm Study to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback